[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Venaxis Inc (APPY)

Venaxis Inc (APPY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Venaxis Inc 1775 38TH STREET BOULDER CO 80301

www.venaxis.com P: 303-545-5550

Sector:

Medical

INDUSTRY GROUPING:

Medical Products

Description:

Venaxis, Inc. is a biomedical diagnostic company focused on the clinical development and commercialization of its blood-based appendicitis test, APPY1. APPY1 is being developed initially for pediatric, adolescent and young adult patients with abdominal pain. Venaxis, Inc., formerly known as AspenBio Pharma, Inc., is based in Castle Rock, Colorado.

Key Statistics

Overview:

Market Capitalization, $K 17,790
Shares Outstanding, K 4,500
% of Insider Shareholders 8.60%
% of Institutional Shareholders 7.42%

Financials:

Annual Sales, $ 200 K
Annual Net Income, $ -8,760 K
Last Quarter Sales, $ 30 K
Last Quarter Net Income, $ -1,710 K

Growth:

1-Year Return 53.91%
3-Year Return -72.79%
5-Year Return -91.74%
5-Year Revenue Growth -54.55%
5-Year Earnings Growth -97.25%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 03/22/17
Earnings Per Share ttm -1.72
EPS Growth vs. Prev Qtr -95.45%
EPS Growth vs. Prev Year -7.50%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-8 on 03/31/16

APPY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -41.70%
Return-on-Assets % -36.00%
Profit Margin % -4,380.00%
Debt/Equity 0.00
Price/Sales 176.15
Price/Cash Flow N/A
Price/Book 1.04
Book Value/Share 3.79
Interest Coverage 0.00
60-Month Beta 2.56
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.